Cicactyl Puts a Carob Extract Into the Cica Conversation, With a Receptor Claim Still Unnamed

Silab Softcare, the compromised skin division of the French actives house Silab, has unveiled Cicactyl, a galactomannan extract drawn from the seeds of the carob tree, Ceratonia siliqua, and positioned for wounds, scabs, erythema, and barrier repair. The ingredient marks the division's tenth anniversary and caps six years of development, according to Silab's own announcement, placing it alongside existing Softcare actives like AD-RESYL for atopic skin and ACNESIUM for acne as part of a single-plant, single-indication product strategy.

What actually goes into a formula is a preservative-free powder standardized to 85% purified galactomannans, used at 0.05% to 1%, a range Silab says spans everything from light daily lotions to more concentrated repair treatments for compromised skin. Silab classifies the material as 100% natural under ISO 16128 and describes it as free of allergenic substances, a claim broad enough that the company extends its recommended use to pregnant and breastfeeding adults and to infants, according to the brand's press materials.

The mechanistic story Silab tells centers on the molecule's size and structure, which the company says give it a strong affinity for a lectin receptor involved in skin repair, though Silab does not name the receptor publicly. That gap matters because galactomannan biology already has a well-documented lectin partner in the scientific literature, and it points the wrong way for a healing claim: Dectin-2, the C-type lectin receptor characterized in a 2022 mBio paper as binding Aspergillus fumigatus galactomannan, is the basis of the clinical galactomannan antigen test used to diagnose invasive aspergillosis, an immune-recognition pathway built around detecting a fungal pathogen rather than repairing tissue.

A better fit for Cicactyl's claimed effects sits with CD206, the macrophage mannose receptor expressed on pro-repair M2 macrophages. Research published in PMC has tied CD206-positive macrophages to granulation tissue formation through interactions with fibroblasts expressing the protein Gpnmb, and structural work on the receptor describes its binding preference for mannose, fucose, and GlcNAc-type sugars, the same sugar chemistry found in galactomannans. Silab's materials never confirm that CD206 is the receptor it means, so the pharmacology that would explain Cicactyl's effect on wounded skin remains an inference drawn from adjacent literature rather than a claim the company has made itself.

The raw material carries its own history outside cosmetics. Carob seed gum is already sold industrially as locust bean gum, E410, a thickener re-evaluated by EFSA in 2017 and used across the food industry, with occasional case reports of occupational respiratory allergy and food allergy tied to the gum, a wrinkle that sits awkwardly next to Silab's non-allergenic framing for a different, more purified fraction of the same polysaccharide family. Locust bean gum demand has also been climbing alongside the plant-based food boom, and reporting on supply initiatives like CarobWay has flagged tightening availability of carob seed stock, meaning a cosmetic actives supplier now draws on the same drought-tolerant Mediterranean tree that food manufacturers are competing for.

Cicactyl arrives into a skin-repair category currently defined by Centella asiatica, the so-called cica ingredient family that built a market now estimated above a billion dollars and still growing by mid-single to high-single digit percentages a year. Silab is not borrowing that branding. It is proposing an entirely different plant source, carob instead of Centella, for the same claims territory of scabs, redness, and re-epithelialization, a bet that the galactomannan chemistry in a legume seed can do what a decade of Centella marketing has already taught consumers to expect from a tube labeled cica cream.